Google Chrome
Safari
Firefox
Edge
Press Clipping / May 29, 2018
The good times keep rolling in pharmaceutical chemicals
C&EN, May 21, 2018
Search
Article / Oct 20, 2020
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Article / Jun 02, 2021
Cleaning Continuous Manufacturing Equipment
Pharmaceutical Technology, 2 Junho 2021
Press Release / Feb 25, 2022
Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Sunriser® DPI
High Performance, High-Dose Capsule DPI.
Article / Apr 06, 2026
Hovione Eyeing Manufacturing Expansion on Both Sides of Atlantic
Contract Pharma, 6 April 2026
Press Release / Aug 01, 2005
Hovione Group sales grow 8% for fiscal year 2004/05
Hovione announces that the consolidated sales volume for the fiscal year ended 31st March 2005 amounted to US$81.4 million, representing a growth of 8% over the previous year.
Press Release / Sep 20, 2019
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
Article / Sep 27, 2021
How the drug services industry found itself prepared for a pandemic
C&EN, 26 September 2021
Press Release / Jan 17, 2023
Hovione is recognized as a Top Employer 2023
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.